This strategist’s theory of relativity says it’s time to be underweight U.S. stocks
Japan and emerging markets should be bought says Ned Davis Research strategist
Japan and emerging markets should be bought says Ned Davis Research strategist
The risk of a calamitous “lost decade” for investors is higher than you think
JPMorgan believes gold will increasingly become an investor favored hedge against equities, to the tune of 110%.
The U.S. government is reportedly considering quantum investments. The technology holds promise, but there have been practical roadblocks.
The CEO of Barclays said the bank wasn’t stuck with exposure to fallen auto-parts company First Brands because of its own due diligence, but it was lumbered with Tricolor exposure.
L’Oreal shares slumped on Wednesday as the chief executive of the highly valued cosmetics company didn’t express huge confidence over upcoming sales.
Price increases offset flat sales in certain business units.
GM doesn’t anticipate tariff costs to be as steep as it previously expected. The automaker is also benefiting from higher prices, and says its move to trim EV production will pay off next year.
The iPhone maker’s shares tend to rise in the last 3 months of the year, says Evercore
An executive at AstraZeneca says breast-cancer drugs that the company highlighted at an industry conference over the weekend could represent $10 billion worth of company sales in five years’ time.